非酒精性脂肪性肝病(NAFLD)与肥胖密切相关,糖尿病,和代谢综合征(MetS),它已经成为最常见的慢性肝病。蠕虫与人类共同进化,诱导多种免疫调节机制来调节宿主的免疫系统。通过利用它们的免疫调节能力,蠕虫及其产品对各种自身免疫和炎性疾病具有保护作用,包括肥胖,糖尿病,和MetS,与NAFLD密切相关。这里,我们从糖脂代谢异常,炎症,和肠道生态失调。相应地,蠕虫及其产品可以治疗或缓解这些NAFLD相关疾病,包括肥胖,糖尿病,和MetS,通过促进糖脂代谢稳态,调节炎症,恢复肠道微生物群的平衡。考虑到已经对蠕虫及其产品进行了大量临床试验,用于治疗炎症性疾病,并取得了有希望的结果,用蠕虫治疗NAFLD和肥胖相关疾病也是一个新的方向和策略。
Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity, diabetes, and metabolic syndrome (MetS), and it has become the most common chronic liver disease. Helminths have co-evolved with humans, inducing multiple immunomodulatory mechanisms to modulate the host\'s immune system. By using their immunomodulatory ability, helminths and their products exhibit protection against various autoimmune and inflammatory diseases, including obesity, diabetes, and MetS, which are closely associated with NAFLD. Here, we review the pathogenesis of NAFLD from abnormal glycolipid metabolism, inflammation, and gut dysbiosis. Correspondingly, helminths and their products can treat or relieve these NAFLD-related diseases, including obesity, diabetes, and MetS, by promoting glycolipid metabolism homeostasis, regulating inflammation, and restoring the balance of gut microbiota. Considering that a large number of clinical trials have been carried out on helminths and their products for the treatment of inflammatory diseases with promising results, the treatment of NAFLD and obesity-related diseases by helminths is also a novel direction and strategy.